Gihad Nesrallah

Associate Scientist
Li Ka Shing Knowledge Institute
University of Toronto
Toronto, Ontario, Canada

Presentation(s):

• 161 - 2022 CCS GUIDELINE FOR USE OF GLP-1 RECEPTOR AGONSISTS AND SGLT2 INHIBITORS FOR CARDIORENAL RISK REDUCTION IN ADULTS

  Thursday, October 27, 2022
  3:15 PM – 4:15 PM EDT

• 127 - PATIENT CASE – RECURRENT EVENT

  Friday, October 28, 2022
  2:16 PM – 2:29 PM EDT

• 127 - Q&A PERIOD

  Friday, October 28, 2022
  2:42 PM – 2:57 PM EDT